|1.||Baldwin, David R: 4 articles (01/2014 - 12/2011)|
|2.||Stanley, Rosamund A: 4 articles (01/2014 - 12/2011)|
|3.||Tata, Laila J: 4 articles (01/2014 - 12/2011)|
|4.||Hubbard, Richard B: 4 articles (01/2014 - 12/2011)|
|5.||Khakwani, Aamir: 3 articles (01/2014 - 02/2013)|
|6.||Rich, Anna L: 3 articles (01/2014 - 12/2011)|
|7.||Powell, Helen A: 3 articles (01/2014 - 02/2013)|
|8.||Tata, L J: 1 article (10/2013)|
|9.||Hubbard, R B: 1 article (10/2013)|
|10.||Baldwin, D R: 1 article (10/2013)|
|1.||Lung Neoplasms (Lung Cancer)
10/15/2013 - "Our aim was to evaluate the changes in survival since the introduction of the National Lung Cancer Audit (NLCA). "
09/01/2013 - "We used the data in the NLCA to develop a predictive score, based on an English population and specific to lung cancer surgery, which estimates risk of death within 90 days; this score should be tested in future cohorts."
09/01/2013 - "We used data from the National Lung Cancer Audit (NLCA) to determine the proportions of English patients who died within 30 and 90 days after surgery for NSCLC. "
02/01/2013 - "The National Lung Cancer Audit (NLCA) recommends that trusts obtain pathology (histology or cytology) for 75% of their lung cancer patients, however this figure was arbitrarily chosen and the optimal pathological confirmation rate is unknown, and many countries report somewhat higher rates. "
02/01/2013 - "The pathological confirmation rate of lung cancer in England using the NLCA database."
|2.||Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/01/2013 - "We calculated the proportion of patients with non-small cell or small cell lung cancer in the NLCA database, first seen between 1st January 2004 and 31st December 2010, who had pathological confirmation of their diagnosis. "
01/01/2014 - "The purpose of this study was to identify trends in survival and chemotherapy use for individuals with small-cell lung cancer (SCLC) in England using the National Lung Cancer Audit (NLCA). "
|4.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
|5.||Body Weight (Weight, Body)
07/01/2004 - "Seventy-three women (body mass index, 26.9 +/- 1.9 kg/m(2)) were recruited either to consume a moderately energy-restricted diet (WL group) or to maintain their body weight [weight-maintenance (WM) group] and were randomly assigned to either the HiCa or the NlCa group in a double-blind manner. "
|1.||Immunoglobulin Light Chains (Immunoglobulin Light Chain)
|4.||Amyloid (Amyloid Fibrils)
|1.||Drug Therapy (Chemotherapy)